isoxazoles has been researched along with Sarcoma, Ewing in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appert, A; Beauchamp, RD; Chung, DH; Lindsley, CW; Padmanabhan, C; Qiao, J; Rellinger, EJ; Waterson, AG | 1 |
1 other study(ies) available for isoxazoles and Sarcoma, Ewing
Article | Year |
---|---|
ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand.
Topics: Antigens, CD; Antineoplastic Agents; Apoptosis; Cadherins; Caspase 3; Cell Cycle; Cell Line, Tumor; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Humans; Isoxazoles; Mesenchymal Stem Cells; Niacinamide; Poly(ADP-ribose) Polymerases; Sarcoma, Ewing; Signal Transduction; Small Molecule Libraries; TNF-Related Apoptosis-Inducing Ligand; Vimentin | 2017 |